• 1
    Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3:77ra29.
  • 2
    Kenya National Bureau of Statistics (KNBS) and ICF Macro. Kenya Demographic and Health Survey 2008–09. Calverton, MD: KNBS and ICF Macro, 2010.
  • 3
    National AIDS and STI Control Programme. Kenya AIDS Indicator Survey 2007. Nairobi, Kenya: Ministry of Health, 2008.
  • 4
    Hindin MJ, Muntifering CJ. Women's autonomy and timing of most recent sexual intercourse in Sub-Saharan Africa: a multi-country analysis. J Sex Res 2011;48:5119.
  • 5
    Cummins JE, Christensen L, Lennox JL, Bush TJ, Wu Z, Malamud D, et al. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load. AIDS Res Hum Retroviruses 2006;22:78896.
  • 6
    Zara F, Nappi RE, Brerra R, Migliavacca R, Maserati R, Spinillo A. Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect 2004;80:10812.
  • 7
    Bollen LJM, Tjong-A-Hung SP, van der Velden J, Mol B-W, ten Kate FWJ, ter Schegget J, et al. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol 1999;72:199201.
  • 8
    Aerssons A, Claeys P, Beerens E, Weyers S, Van Renterghem L, Praet M, et al. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia. Cytopathology 2009;20:2735.
  • 9
    Wright TC Jr, Subbarao S, Ellerbrock TV, Lennox JL, Evans-Strickfaden T, Smith DG, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 2001;184:27985.
  • 10
    Chung MH, McKenzie KP, Richardson BA, John-Stewart GC, Coombs RW, De Vuyst H, et al. Cervical HIV-1 RNA shedding after cryotherapy among HIV-positive women with cervical intraepithelial neoplasia stage 2 or 3. AIDS 2011;25:19159.
  • 11
    WHO. ART for HIV Infection in Adults and Adolescents in Poor Settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization, 2006.
  • 12
    Huchko MJ, Maloba M, Bukusi EA. Safety of the loop electrosurgical excision procedure performed by clinical officers in an HIV primary care setting. Int J Gynaecol Obstet 2010;111:8990.
  • 13
    Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, et al. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis 2001;184:118791.
  • 14
    Anderson BL, Cu-Uvin S. Determinants of HIV shedding in the lower genital tract of women. Curr Infect Dis Rep 2008;10:50511.
  • 15
    Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007;21:5017.
  • 16
    Lawn SD, Subbarao S, Wright TC Jr, Evans-Strickfaden T, Ellerbrock TV, Lennox JL, et al. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis 2000;181:19506.
  • 17
    Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012;205:35865.
  • 18
    Woo VG, Cohen CR, Bukusi EA, Huchko MJ. Loop electrosurgical excision procedure: safety and tolerability among human immunodeficiency virus-positive kenyan women. Obstet Gynecol 2011;118:5549.